Skip to main content

This site is intended for US residents.

OJEMDA (tovorafenib) logo: 100 mg tablets 25 mg/mL for oral suspension

Holmes, lives with pLGG

EveryDay Support From Day One™

We’re here to support you at each step of your child’s journey with OJEMDA

EveryDay Support From Day One offers guidance from dedicated Patient Navigators, financial assistance programs for eligible patients, insurance coverage support, treatment and administration education, and more.

Dedicated Patient Navigators

Our Patient Navigators will work directly with you to address your specific needs and coordinate with your child’s care team to simplify the process of getting OJEMDA.

Coverage support

We work with your child’s care team and health insurance plan to help obtain coverage.

Financial assistance

We provide financial assistance programs to help eligible families pay for OJEMDA, including the OJEMDA Copay Program,* which can lower out-of-pocket costs to as little as $0 per month, and a program that may provide free medicine if you don’t have health insurance or are underinsured for OJEMDA.

*Restrictions and eligibility requirements apply. Not available for those with government insurance. Maximum benefit applies. Please see for full terms and conditions.

Additional terms and conditions may apply.

Shipment & medication support

We work with our specialty pharmacy partners to ship OJEMDA directly to your home address and provide ongoing prescription and treatment support.

Here to help your child start and stay on therapy—join the program today

Get started at or call 855-DAY1-BIO (855-329-1246) Monday-Friday, 8 AM - 8 PM ET

By enrolling in EveryDay Support From Day One, you’ll receive resources and support throughout your child’s journey with OJEMDA. Get resources, answers to your questions, and assistance with the next steps that are right for you. EveryDay Support From Day One is available to you at no cost.


Before taking or giving OJEMDA, tell your healthcare provider about all of your or your child’s medical conditions, including if you:

  • have bleeding, skin, or liver problems
  • are pregnant or plan to become pregnant. OJEMDA can harm your unborn baby.

Females who are able to become pregnant:

  • You should use effective non-hormonal birth control (contraception) during treatment with OJEMDA and for 28 days after your last dose of OJEMDA.

Males with female partners who are able to become pregnant should use effective non-hormonal birth control (contraception) during treatment with OJEMDA and for 2 weeks after your last dose of OJEMDA.

  • are breastfeeding or plan to breastfeed. Do not breastfeed during treatment and for 2 weeks after your last dose of OJEMDA.

Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.

What should I avoid while taking OJEMDA?

Limit the amount of time you spend in sunlight. OJEMDA can make your skin sensitive to the sun (photosensitivity). Use sun protection measures, such as sunscreen, sunglasses and wear protective clothes that cover your skin during your treatment with OJEMDA.

What are the possible side effects of OJEMDA?

OJEMDA may cause serious side effects, including:

  • bleeding problems (hemorrhage) are common and can also be serious. Tell your healthcare provider if you develop any signs or symptoms of bleeding, including:
    • headache, dizziness or feeling weak
    • coughing up blood or blood clots
    • vomiting blood or your vomit looks like "coffee grounds"
    • red or black stools that look like tar
  • skin reactions, including sensitivity to sunlight (photosensitivity). OJEMDA can cause skin reactions that can become severe. Tell your healthcare provider if you get new or worsening skin reactions, including:
    • rash
    • bumps or tiny papules
    • acne
    • peeling, redness, or irritation
    • blisters
  • liver problems. Your healthcare provider will do blood tests to check your liver function before and during treatment with OJEMDA. Tell your healthcare provider right away if you develop any of the following symptoms:
    • yellowing of your skin or your eyes
    • dark or brown (tea-colored) urine
    • nausea or vomiting
    • loss of appetite
    • tiredness
    • bruising
    • bleeding
    • pain in your upper right stomach area
  • slowed growth in children. Growth will be checked routinely during treatment with OJEMDA.

The most common side effects of OJEMDA include:

  • rash
  • hair color changes
  • tiredness
  • viral infection
  • vomiting
  • headache
  • fever
  • dry skin
  • constipation
  • nausea
  • acne
  • upper respiratory tract infection

OJEMDA may cause fertility problems in males and females, which may affect your ability to have children.


What is OJEMDA™ (tovorafenib)?

OJEMDA is a prescription medicine used to treat certain types of brain tumors (cancers) called gliomas in patients 6 months and older:

  • that is a pediatric low-grade glioma (LGG), and
  • that has come back after previous treatment or has not responded to previous treatment and
  • that has a certain type of abnormal “BRAF” gene.

These are not all the possible side effects of OJEMDA. Call your healthcare provider for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

Please see full Patient Information, including Instructions for Use, for more information.